-
Multi-Center Study of the 99th Percentile Value of High-Sensitivity Troponin I in A Normal Healthy Chinese Population
Renqian Zhong, Hao Wang, Zhihua Tao, Qingfeng Chen, Zheng Zhang, Xiaoyun Pu, Lianming Wang, Wei Chen, Hui Yuan, Yingping Cao, Xing Gao, Yijie Zheng, Peng Yin
Research Article: Clinical Investigation
-
Multi-Center Study of the 99th Percentile Value of High-Sensitivity Troponin I in A Normal Healthy Chinese Population
Renqian Zhong, Hao Wang, Zhihua Tao, Qingfeng Chen, Zheng Zhang, Xiaoyun Pu, Lianming Wang, Wei Chen, Hui Yuan, Yingping Cao, Xing Gao, Yijie Zheng, Peng Yin
Research Article: Clinical Investigation
-
Multi-Center Study of the 99th Percentile Value of High-Sensitivity Troponin I in A Normal Healthy Chinese Population
Renqian Zhong, Hao Wang, Zhihua Tao, Qingfeng Chen, Zheng Zhang, Xiaoyun Pu, Lianming Wang, Wei Chen, Hui Yuan, Yingping Cao, Xing Gao, Yijie Zheng, Peng Yin
Research Article: Clinical Investigation
-
Multi-Center Study of the 99th Percentile Value of High-Sensitivity Troponin I in A Normal Healthy Chinese Population
Renqian Zhong, Hao Wang, Zhihua Tao, Qingfeng Chen, Zheng Zhang, Xiaoyun Pu, Lianming Wang, Wei Chen, Hui Yuan, Yingping Cao, Xing Gao, Yijie Zheng, Peng Yin
Research Article: Clinical Investigation
-
Multi-Center Study of the 99th Percentile Value of High-Sensitivity Troponin I in A Normal Healthy Chinese Population
Renqian Zhong, Hao Wang, Zhihua Tao, Qingfeng Chen, Zheng Zhang, Xiaoyun Pu, Lianming Wang, Wei Chen, Hui Yuan, Yingping Cao, Xing Gao, Yijie Zheng, Peng Yin
Research Article: Clinical Investigation
-
Multi-Center Study of the 99th Percentile Value of High-Sensitivity Troponin I in A Normal Healthy Chinese Population
Renqian Zhong, Hao Wang, Zhihua Tao, Qingfeng Chen, Zheng Zhang, Xiaoyun Pu, Lianming Wang, Wei Chen, Hui Yuan, Yingping Cao, Xing Gao, Yijie Zheng, Peng Yin
Research Article: Clinical Investigation
-
Multi-Center Study of the 99th Percentile Value of High-Sensitivity Troponin I in A Normal Healthy Chinese Population
Renqian Zhong, Hao Wang, Zhihua Tao, Qingfeng Chen, Zheng Zhang, Xiaoyun Pu, Lianming Wang, Wei Chen, Hui Yuan, Yingping Cao, Xing Gao, Yijie Zheng, Peng Yin
Research Article: Clinical Investigation
-
Multi-Center Study of the 99th Percentile Value of High-Sensitivity Troponin I in A Normal Healthy Chinese Population
Renqian Zhong, Hao Wang, Zhihua Tao, Qingfeng Chen, Zheng Zhang, Xiaoyun Pu, Lianming Wang, Wei Chen, Hui Yuan, Yingping Cao, Xing Gao, Yijie Zheng, Peng Yin
Research Article: Clinical Investigation
-
Vosaroxin for acute myeloid leukemia
Joelle El-Amm & Imad A Tabbara
Review: Clinical Trail Outcomes: Clinical Investigation
-
Vosaroxin for acute myeloid leukemia
Joelle El-Amm & Imad A Tabbara
Review: Clinical Trail Outcomes: Clinical Investigation
-
Vosaroxin for acute myeloid leukemia
Joelle El-Amm & Imad A Tabbara
Review: Clinical Trail Outcomes: Clinical Investigation
-
Vosaroxin for acute myeloid leukemia
Joelle El-Amm & Imad A Tabbara
Review: Clinical Trail Outcomes: Clinical Investigation
-
Vosaroxin for acute myeloid leukemia
Joelle El-Amm & Imad A Tabbara
Review: Clinical Trail Outcomes: Clinical Investigation
-
Vosaroxin for acute myeloid leukemia
Joelle El-Amm & Imad A Tabbara
Review: Clinical Trail Outcomes: Clinical Investigation
-
Vosaroxin for acute myeloid leukemia
Joelle El-Amm & Imad A Tabbara
Review: Clinical Trail Outcomes: Clinical Investigation
-
Vosaroxin for acute myeloid leukemia
Joelle El-Amm & Imad A Tabbara
Review: Clinical Trail Outcomes: Clinical Investigation
-
Trial discontinuation: lessons for future trial design?
Veerle JAA Nuij, Colin J de Haar & C Janneke van der Woude
Clinical Trail Methodology: Clinical Investigation
-
Trial discontinuation: lessons for future trial design?
Veerle JAA Nuij, Colin J de Haar & C Janneke van der Woude
Clinical Trail Methodology: Clinical Investigation
-
Trial discontinuation: lessons for future trial design?
Veerle JAA Nuij, Colin J de Haar & C Janneke van der Woude
Clinical Trail Methodology: Clinical Investigation
-
Trial discontinuation: lessons for future trial design?
Veerle JAA Nuij, Colin J de Haar & C Janneke van der Woude
Clinical Trail Methodology: Clinical Investigation
-
Trial discontinuation: lessons for future trial design?
Veerle JAA Nuij, Colin J de Haar & C Janneke van der Woude
Clinical Trail Methodology: Clinical Investigation
-
Trial discontinuation: lessons for future trial design?
Veerle JAA Nuij, Colin J de Haar & C Janneke van der Woude
Clinical Trail Methodology: Clinical Investigation
-
Trial discontinuation: lessons for future trial design?
Veerle JAA Nuij, Colin J de Haar & C Janneke van der Woude
Clinical Trail Methodology: Clinical Investigation
-
Trial discontinuation: lessons for future trial design?
Veerle JAA Nuij, Colin J de Haar & C Janneke van der Woude
Clinical Trail Methodology: Clinical Investigation
-
Distrust and minority trial participation: more than meets the eye
Raegan W Durant
Editorial: Clinical Investigation
-
Distrust and minority trial participation: more than meets the eye
Raegan W Durant
Editorial: Clinical Investigation
-
Distrust and minority trial participation: more than meets the eye
Raegan W Durant
Editorial: Clinical Investigation
-
Distrust and minority trial participation: more than meets the eye
Raegan W Durant
Editorial: Clinical Investigation
-
Distrust and minority trial participation: more than meets the eye
Raegan W Durant
Editorial: Clinical Investigation
-
Distrust and minority trial participation: more than meets the eye
Raegan W Durant
Editorial: Clinical Investigation
-
Distrust and minority trial participation: more than meets the eye
Raegan W Durant
Editorial: Clinical Investigation
-
Distrust and minority trial participation: more than meets the eye
Raegan W Durant
Editorial: Clinical Investigation
-
Parkinsons disease: will therapy move beyond dopaminergic medication?
Livia Dezsi,L Vecsei
Review Article: Clinical Investigation
-
Parkinsons disease: will therapy move beyond dopaminergic medication?
Livia Dezsi,L Vecsei
Review Article: Clinical Investigation
-
Parkinsons disease: will therapy move beyond dopaminergic medication?
Livia Dezsi,L Vecsei
Review Article: Clinical Investigation
-
Parkinsons disease: will therapy move beyond dopaminergic medication?
Livia Dezsi,L Vecsei
Review Article: Clinical Investigation
-
Parkinsons disease: will therapy move beyond dopaminergic medication?
Livia Dezsi,L Vecsei
Review Article: Clinical Investigation
-
Parkinsons disease: will therapy move beyond dopaminergic medication?
Livia Dezsi,L Vecsei
Review Article: Clinical Investigation
-
Parkinsons disease: will therapy move beyond dopaminergic medication?
Livia Dezsi,L Vecsei
Review Article: Clinical Investigation
-
Parkinsons disease: will therapy move beyond dopaminergic medication?
Livia Dezsi,L Vecsei
Review Article: Clinical Investigation